Home/Healthcare/Biotechnology/Global Genetic Testing Market

Global Genetic Testing Market Size, Share, Opportunities, And Trends By Type (Prenatal Testing, New Born Screening, Diagnostic Testing, Carrier Testing, Predictive & Pre-symptomatic Testing), By Diseases (Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne’s Muscular Dystrophy, Alzheimer’s Diseases, Thalassemia, Huntington’s Disease, Others), By Technology (Introduction, Cyto-Genetics Testing, Biochemical Testing, Molecular Testing), And By Geography - Forecasts From 2025 To 2030

$3,950
Single User License

Report Overview

Genetic Testing Market Size:

The Global Genetic Testing Market is expected to grow from USD 14.904 billion in 2025 to USD 24.889 billion in 2030, at a CAGR of 10.80%.

The global genetic testing demand is driven by a number of factors such as the aging global population, rising incidences of genetic and hereditary diseases, growing awareness, technological advancements, and a rise in the application of genetic testing for the early detection of various diseases.

With the development of new technologies and innovation in both scientific research and research equipment, genetic testing is headed toward an era of high significance in the near future.  As investments in research and development related to genetic testing increase, the global genetic testing market is expected to witness a substantial boost in its overall growth in the next five years.

Genetic Testing Market Geographical Outlook:

North America holds the largest share in the global genetic testing market owing to technological advancements, the rising prevalence of genetic diseases, and the high quality of infrastructure to support the genetic testing industry in the region. However, emerging economies hold good potential for the growth of the genetic testing market due to factors such as a rising patient pool, more government funding supporting investment in the industry, and growing awareness regarding the technology. APAC region will witness the fastest market growth owing to the rising aging population, rising purchasing power, and technological advancements in the region. However, the high cost of genetic testing coupled with unclear reimbursement structure, lack of skilled personnel, and lack of regulations in the market will restrain the growth of this market during the forecast period.

Genetic Testing Market Research Methodology:

The report provides a brief introduction to the market and deals with detailed research methodology for calculating market size and forecasts, secondary data sources used, and the primary inputs which were taken for data validation. This section also outlines various segments which have been covered as part of the report.

Genetic Testing Market Dynamics:

The next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities that exist in the current market. This section of the report also provides global and regional regulations that determine the market growth and industry value chain analysis of the genetic testing market. Complete industry analysis has also been covered by Porter’s five forces model as a part of this report section.

Genetic Testing Market Competitive Insight

The major players discussed in this report include F. Hoffmann-La Roche Ltd[1], 23&Me, Inc., Precipio, Inc., AutoGenomics, Abbott Laboratories, and Luminex Corporation among a few others.

Segmentation

The genetic testing market has been segmented by product type, diseases, technology, and geography:

  • By Type
    • Prenatal Testing
    • New Born Screening
    • Diagnostic Testing
    • Carrier Testing
    • Predictive & Pre-symptomatic Testing
  • By Diseases
    • Cancer
    • Cystic Fibrosis
    • Sickle Cell Anemia
    • Duchenne’s Muscular Dystrophy
    • Alzheimer’s Diseases
    • Thalassemia
    • Huntington’s Disease
    • Others
  • By Technology
    • Cyto-genetics Testing
    • Biochemical Testing
    • Molecular Testing
    • Others
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
      • Others
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Italy
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Others

Market Segmentation

By Type

Prenatal Testing
New Born Screening
Diagnostic Testing
Carrier Testing
Predictive & Pre-symptomatic Testing

By Disease

Cancer
Cystic Fibrosis
Sickle Cell Anemia
Duchenne’s Muscular Dystrophy
Alzheimer’s Disease
Thalassemia
Huntington’s Disease
Others

By Technology

Cyto-genetics Testing
Biochemical Testing
Molecular Testing
Others

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Others
Middle East & Africa
Saudi Arabia
UAE
Others
Asia Pacific
Japan
China
India
Australia
Others

Table of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK 

5. GLOBAL GENETIC TESTING MARKET BY TYPE

5.1. Introduction

5.2. Prenatal Testing

5.3. New Born Screening

5.4. Diagnostic Testing

5.5. Carrier Testing

5.6. Predictive & Pre-symptomatic Testing

6. GLOBAL GENETIC TESTING MARKET BY DISEASE

6.1. Introduction

6.2. Cancer

6.3. Cystic Fibrosis

6.4. Sickle Cell Anemia

6.5. Duchenne’s Muscular Dystrophy

6.6. Alzheimer’s Disease

6.7. Thalassemia

6.8. Huntington’s Disease

6.9. Others

7. GLOBAL GENETIC TESTING MARKET BY TECHNOLOGY

7.1. Introduction

7.2. Cyto-genetics Testing

7.3. Biochemical Testing

7.4. Molecular Testing

7.5. Others

8. GLOBAL GENETIC TESTING MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil 

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Others

8.5. Middle East & Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. Australia

8.6.5. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. F. Hoffmann-La Roche Ltd

10.2. Abbott Laboratories

10.3. Precipio, Inc.

10.4. Ariosa Diagnostics, Inc.

10.5. Biocartis SA

10.6. Danaher Corporation

10.7. 23&Me, Inc.

10.8. DiaSorin

10.9. Labcorp

10.10. AutoGenomics 

10.11. Illumina, Inc 

10.12. Thermo Fisher Scientific

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Request Customization

Tell us your specific requirements and we will customize this report for you.

📞

Your data is secure. We do not share information with any third party.

Download Free Sample

Get a sample copy of this report with charts, TOC, and methodology.

📞

Your data is secure. We do not share information with any third party.

Speak to Analyst

Ask our analysts any questions you have about this market research report.

📞

Your data is secure. We do not share information with any third party.

Global Genetic Testing Market Report

Report IDKSI061610991
PublishedAug 2025
Pages140
FormatPDF, Excel, PPT, Dashboard

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Frequently Asked Questions

The genetic testing market is expected to reach a total market size of US$24.889 billion by 2030.

Genetic Testing Market is valued at US$14.904 billion in 2025.

The genetic testing market is expected to grow at a CAGR of 10.80% during the forecast period.

The global genetic testing demand is driven by a number of factors such as the aging global population, rising incidences of genetic and hereditary diseases, growing awareness, technological advancements, and a rise in the application of genetic testing for the early detection of various diseases.

North America holds the largest share in the global genetic testing market owing to technological advancements, the rising prevalence of genetic diseases, and the high quality of infrastructure to support the genetic testing industry in the region.

Need data specifically for your business?Request Custom Research →
Related Reports

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon